Jan
31
Wed
Precision Medicine in Cancer Prevention and Screening @ Li Ka Shing, Berg Hall A-B
Jan 31 @ 1:00 pm – 2:00 pm

UnknownPresenter: Douglas Lowy, MD
Deputy Director, NCI/NIH 

MIPS is launching a new seminar series, IMAGinING THE FUTURE, aimed at catalyzing interdisciplinary discussions in all areas of medicine and disease.

This seminar series is open and free to everyone in the Stanford community, as well as anyone from the surrounding community, universities, companies, or institutions. Register here for the January 31 seminar.

Douglas Lowy, M.D., is the Deputy Director of the National Cancer Institute (NCI) of the National Institutes of Health (NIH). Lowy previously served as NCI’s deputy director, helping lead NCI’s key scientific initiatives since 2010.

A cancer researcher for more than 40 years, Lowy received the National Medal of Technology and Innovation from President Obama in 2014 for his research that led to the development of the human papillomavirus (HPV) vaccine. As chief of the Laboratory of Cellular Oncology in the Center for Cancer Research at NCI, Lowy’s research includes the biology of papillomaviruses and the regulation of normal and neoplastic growth. His laboratory, in close collaboration with John T. Schiller, Ph.D., was involved in the initial development, characterization, and clinical testing of the preventive virus-like particle-based HPV vaccines that are now used in the three U.S. Food and Drug Administration-approved HPV vaccines.

Lowy is a member of the National Academy of Sciences (NAS), as well as the Institute of Medicine of the NAS. For their pioneering work, Lowy and Schiller have received numerous honors in addition to the National Medal, including the 2011 Albert B. Sabin Gold Medal Award and the Federal Employee of the Year Award in 2007 from the Partnership for Public Service.

Lowy received his medical degree from New York University School of Medicine, New York City, and trained in internal medicine at Stanford University, California, and dermatology at Yale University, New Haven, Connecticut.

Dec
4
Wed
Medicine Grand Rounds: Optimizing Bone Health in Breast Cancer @ LKSC Berg Hall
Dec 4 @ 8:00 am – 9:00 am
Medicine Grand Rounds: Optimizing Bone Health in Breast Cancer @ LKSC Berg Hall | Palo Alto | California | United States

Presenter: Joy Wu, MD

Assistant Professor of Endocrinology, Stanford University

Joy Wu, MD, is a board-certified endocrinologist with over 12 years’ experience who specializes in treating women and men with osteoporosis and other bone and mineral diseases, including primary hyperparathyroidism, vitamin D deficiency, Paget’s disease and fibrous dysplasia. She has a special interest in optimizing skeletal health for those at risk of bone loss from glucocorticoid treatment, cancer therapies, or organ transplant. She works closely with each individual and his/her referring physician to assess fracture risk, and to develop a tailored treatment and monitoring plan.

Wu directs a broad basic and translational research program that focuses on skeletal development and the bone marrow hematopoietic niche. Her laboratory is currently studying stem cell therapies for bone formation, and the prevention of cancer metastases to bone (joywulab.stanford.edu). She has been honored with awards from the NIH Director’s New Innovator Award, the Endocrine Society, the American Society for Bone and Mineral Research, and the Mary Kay Foundation. Dr. Wu is committed to training the next generation of physician scientists, and serves as Co-Director of the Stanford Internal Medicine Translational Investigator Program.